- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00716261
Bio-Feedback to Improving Stability in Elderly Population
July 15, 2008 updated by: Tel-Aviv Sourasky Medical Center
Using Bio-Feedback for Improving Stability in Walking and Everyday Activity
Our hypothesis is that intensive training with positive biofeedback may enhance postural control and stability in Parkinson's disease patients and in elderly fallers.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to treat Parkinson's patients and elderly fallers.
The intervention is intensive training with Biofeedback to try to correct stooped posture, and to improve stability in standing and in walking.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel-Aviv, Israel, 64239
- Laboratory for gait and neurodynamics, Tel-Aviv Sourasky Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Idiopathic PD for >2 yrs
- Between 50-90 Yrs
- On anti-Parkinsonian medication
- Hoehn & Yahr 2-3 in "ON"
- Free of serious co-morbidities
- Able to walk but reports difficulties in gait
- Can use assistive device
Exclusion Criteria:
- Significant orthopedic disturbances or pain
- Major depression (DSM IV)
- Dementia (MMSE<24)
- Clinically significant hearing problems
- Unstable medical condition (2 wks from meds change)
- Deep Brain Stimulation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jeffrey M Hausdorff, PhD, Laboratory for gait and neurodynamics, Tel-Aviv Sourasky Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Anticipated)
September 1, 2009
Study Completion (Anticipated)
November 1, 2009
Study Registration Dates
First Submitted
July 14, 2008
First Submitted That Met QC Criteria
July 15, 2008
First Posted (Estimate)
July 16, 2008
Study Record Updates
Last Update Posted (Estimate)
July 16, 2008
Last Update Submitted That Met QC Criteria
July 15, 2008
Last Verified
July 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0204-08-TLV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease Patients
-
University Hospital, GrenobleCommissariat A L'energie AtomiqueRecruitingHealthy Volunteers | Parkinson's Disease Patients | Para/Tetraplegic PatientsFrance
-
University Hospital, RouenRecruiting
-
Hacettepe UniversityCompletedPatients With Parkinson's DiseaseTurkey
-
University Hospital, RouenRecruitingPatients With Parkinson's Disease Treated With Apomorphine PumpsFrance
-
University Hospital, Clermont-FerrandUniversity Hospital, Rouen; Centre Hospitalier Universitaire de Saint Etienne; H. Lundbeck A... and other collaboratorsUnknownApathy | Drug-naïve Patients With Parkinson's DiseaseFrance
-
Assistance Publique Hopitaux De MarseilleCompletedPatients With Parkinson's DiseaseFrance
-
University of California, Los AngelesUniversity of California, San Diego; The Cleveland Clinic; University of California... and other collaboratorsCompletedParkinson's Disease Patients Undergoing Deep Brain Stimulation (DBS) SurgeryUnited States
-
National Taiwan University HospitalCompletedPostural and Suprapostural Performance During Dual Tasking in Patients With Parkinson's DiseaseTaiwan
-
Yonsei UniversityCompletedLevodopa Induced Dyskinesia in Patients With Parkinson's DiseaseKorea, Republic of
-
Escape Bio, Inc.Momentum Pharma; Science 37TerminatedPatients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) GeneUnited States
Clinical Trials on McROB Hybrid node 3-axes accelerometers and 3-axes gyroscopes
-
Tel-Aviv Sourasky Medical CenterUnknown